Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. [electronic resource]
- AIDS research and human retroviruses Jan 2012
- 87-94 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1931-8405
10.1089/aid.2011.0035 doi
Adolescent Anti-HIV Agents--therapeutic use Central African Republic--epidemiology Child Child, Preschool Cross-Sectional Studies Drug Resistance, Viral--drug effects Female Follow-Up Studies HIV Infections--drug therapy HIV-1--genetics Humans Male Mutation--drug effects RNA, Viral--blood Treatment Outcome Viral Load--drug effects